Order MEDIDERMA® MELASES TRX TCA PEEL 10% for Clinics

MEDIDERMA® MELASES TRX TCA PEEL 10% is a professional topical chemical peel for clinic-administered facial resurfacing and pigment-management protocols. Licensed clinics and healthcare professionals can order the 50 ml bottle for treatment-room use, staff-controlled application, and documented peel series. The 10% TCA format supports structured workflows that target uneven tone, dyschromia, and texture refinement in appropriately screened candidates.

Med Wholesale Supplies serves licensed clinics, med spas, and healthcare professionals sourcing authentic brand-name aesthetic products through vetted distributors and verified supply channels. This peel is intended for trained professional handling, not retail consumer self-application.

Clinic Price, 50 ml Bottle, and Ordering Details

Sign in to view the current Mediderma Melases TRX TCA Peel 10% price for your professional account. Pricing may depend on account status, volume planning, and contract tiers, so clinics should align ordering with projected peel series, staff schedules, and room utilization. SKU 89815 identifies the 50 ml bottle for procurement and inventory records.

The bottle format is practical for clinics that need consistent access to a medium-strength professional peel across multiple treatment rooms. It helps teams plan cost per treatment without converting a retail pack into a clinical-use workflow. For broader category planning, browse professional peels and masks alongside this preparation.

Quick tip: Match order quantities to scheduled series volume, training needs, and expiration control rather than stocking by single appointments alone.

What the Peel Is and How It Works

MEDIDERMA® MELASES TRX TCA PEEL 10% is a clinic-use chemical peel formulated around trichloroacetic acid, commonly abbreviated as TCA. TCA is a keratocoagulant acid used by trained providers to create controlled epidermal exfoliation. In professional protocols, this activity can help shed dull surface layers and support a more uniform appearance over time.

The formulation pairs TCA with adjunct brightening and antioxidant agents listed in current product materials: kojic acid, ascorbic acid, phytic acid, and retinol. These ingredients support pigment-balancing routines by combining exfoliation with tone-oriented cosmetic actives. The result is a Melases TRX TCA 10% chemical peel that can fit into a stepwise aesthetic plan for dyschromia, uneven tone, and textural dullness.

Application is topical and performed by qualified staff. Technique, contact time, number of passes, neutralization or removal steps, and interval planning should follow clinic protocols, manufacturer guidance, professional training, and the supervising clinician’s assessment. Typical transient responses after chemical peeling can include warmth, erythema, tightness, dryness, flaking, and visible desquamation over several days.

Professional Applications in Pigment and Texture Protocols

This peel is used in aesthetic workflows focused on dyschromia, mottled tone, melasma-prone presentations, photoaged appearance, and lackluster texture. Clinics may use it in pigment-balancing series, seasonal resurfacing plans, or preparatory routines before other non-ablative aesthetic services when the patient profile is suitable. Screening remains important because peel tolerance can vary by Fitzpatrick type, barrier status, recent procedures, topical retinoid use, and history of post-inflammatory hyperpigmentation.

The Mediderma professional range includes peel and skincare protocols designed for clinic-led cosmetic treatment plans. Practices already using Mediderma systems can integrate this TCA peel into existing documentation, consent, aftercare, and follow-up pathways. Teams expanding pigment-focused services can also review the educational article on chemical peels for hyperpigmentation for broader treatment-planning context.

When appropriate, clinicians may pair the peel with clinic-selected boosters, antioxidants, barrier-support creams, or sun-protection regimens. These adjuncts should be selected according to the individual’s tolerance, recent aesthetic history, and the practice’s written protocol. Patients with active irritation, compromised barrier function, photosensitivity risks, or recent aggressive resurfacing may require deferral or an alternate plan.

Key Features for Treatment-Room Use

• Professional-use 10% TCA peel for controlled topical exfoliation under trained supervision.
• 50 ml bottle supports repeated clinic applications and planned treatment series.
• Formulation includes TCA with kojic acid, ascorbic acid, phytic acid, and retinol.
• Designed for pigment-management and tone-refinement workflows in suitable candidates.
• Uniform liquid handling supports even application when staff follow protocol.
• Labeling with lot and expiry details supports audit-friendly inventory control.
• Compatible with documented intake, consent, treatment notes, and aftercare instructions.
• Known in some clinic catalogs as Mediderma TCA Peel 10% solution.

The product should be stored, handled, and applied according to manufacturer instructions and your practice’s chemical-peel policy. Staff training should include patient selection, degreasing or preparation steps, eye and mucosal protection, controlled application technique, endpoint recognition, and post-peel care communication.

Composition and Ingredient Roles

The active acid system centers on trichloroacetic acid. In a 10% peel solution, TCA supports superficial-to-controlled epidermal exfoliation when applied by trained professionals. Its clinical value depends not only on concentration but also on skin preparation, application time, layering, patient selection, and post-procedure care.

Because the peel contains multiple active ingredients, clinics should record relevant topical product use during intake. Recent retinoids, exfoliating acids, photosensitizing agents, depilatory treatments, or other resurfacing procedures can influence tolerance. The supervising clinician should adjust timing and preparation steps accordingly.

Safety, Contraindication Checks, and Aftercare Planning

Chemical peels require careful candidate selection. Before using MEDIDERMA® MELASES TRX TCA PEEL 10%, clinics should screen for active infection, open wounds, dermatitis, recent sunburn, impaired healing, known ingredient sensitivity, recent isotretinoin history when relevant to practice policy, tendency toward keloids, pregnancy or lactation considerations under clinic policy, and any condition that may increase complication risk. A medical lead should define exclusion criteria and escalation steps.

Expected temporary responses may include erythema, warmth, stinging, tightness, dryness, flaking, scaling, and sensitivity. More concerning reactions can include excessive burning, blistering, crusting, infection signs, pigment darkening or lightening, scarring, or prolonged inflammation. Patients should receive written aftercare that emphasizes gentle cleansing, barrier support, avoiding picking, avoiding unapproved actives, and strict photoprotection.

Sun exposure is a major practical factor in pigment protocols. Clinics should reinforce broad-spectrum sun protection and avoidance of tanning before and after peel procedures, especially for patients prone to melasma or post-inflammatory hyperpigmentation. Follow-up appointments help staff document response, modify intervals, and decide whether the next session should proceed, be delayed, or be adjusted.

Inventory, Handling, and Documentation

The 50 ml bottle should be incorporated into a controlled treatment-room inventory process. Record the SKU, lot number, expiry date, opening date if your policy requires it, operator, and treatment-room location. Staff should avoid transferring product into unlabelled containers and should use clinic-approved applicators, protective equipment, and spill procedures for acid products.

Professional documentation should connect the peel to the patient’s indication, skin type, consent, pre-peel preparation, application time or layers, observed endpoints, post-care instructions, and follow-up plan. This reduces variation between providers and supports consistent outcomes across a multi-room aesthetic practice.

Orders are supported through US distribution with temperature-controlled handling when required and tracked US delivery. Clinics should inspect packaging on receipt, reconcile units against purchase records, and rotate stock by expiry. If your practice uses multiple peel strengths or brands, separate storage zones and clear shelf labels can reduce selection errors.

Protocol Pairings and Related Mediderma Options

Clinics building a pigment-focused Mediderma menu may pair this TCA peel with complementary products from the same professional ecosystem. The Melases TRX Booster Peel may be considered when a protocol calls for an adjunct brightening step rather than a direct substitute for 10% TCA. Selection should follow training, ingredient tolerance, and the desired downtime profile.

For skincare support around dyschromia protocols, teams may evaluate Azelac RU, Azelac RU Liposomal Serum, or Azelac RU Depigmenting Luminous Fluid Cream SPF50. These related products can support clinic-designed brightening and sun-care routines, but they should be introduced according to barrier tolerance and aftercare timing.

Clinics comparing peel approaches may also review Ferulac Peel Plus and the broader professional skincare category. For practical brand context, the article on the Mediderma peel and skincare range can help teams map adjacent products to service menus.

Availability and Substitution Planning

MEDIDERMA® MELASES TRX TCA PEEL 10% can be ordered for licensed clinic procurement through a professional account. Practices planning high-volume peel seasons should review projected demand before promotional campaigns, staff training events, or multi-session treatment blocks. This helps avoid last-minute substitutions that may disrupt protocol consistency.

If a preferred peel strength or related product is temporarily constrained, your medical lead should assess any substitute by acid system, active ingredients, downtime expectations, Fitzpatrick suitability, and aftercare requirements. A product with a similar category role is not automatically interchangeable. Staff should update consent forms, treatment notes, and post-care sheets before adopting a different peel.

Authoritative Sources

• MedlinePlus chemical peel overview
• NIH PubChem record for trichloroacetic acid

Ready to add this TCA chemical peel 10% solution to your clinic menu? Sign in to view account pricing, order the 50 ml bottle, and coordinate purchasing with your documented peel protocols.

This content is for informational purposes only and is not a substitute for professional medical advice.